Literature DB >> 10490363

CagA status and gastric cancer unreliable serological tests produce unreliable data.

Y Yamaoka, D Y Graham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10490363     DOI： 10.1016/s0016-5085(99)70476-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  5 in total

Review 1.  Biomarkers for Helicobacter pylori infection and gastroduodenal diseases.

Authors:  Seiji Shiota; Yoshio Yamaoka
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

2.  New serological assay for detection of putative Helicobacter pylori virulence factors.

Authors:  Chang-Young Park; Yong-Kyun Cho; Tadashi Kodama; Hala M T El-Zimaity; Michael S Osato; David Y Graham; Yoshio Yamaoka
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

3.  Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries.

Authors:  Seiji Shiota; Osamu Matsunari; Masahide Watada; Yoshio Yamaoka
Journal:  Future Microbiol       Date:  2010-12       Impact factor: 3.165

4.  Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan.

Authors:  Seiji Shiota; Kazunari Murakami; Tadayoshi Okimoto; Masaaki Kodama; Yoshio Yamaoka
Journal:  J Gastroenterol Hepatol       Date:  2014-01       Impact factor: 4.029

5.  Chronic Gastritis Is Associated with a Decreased High-Density Lipid Level: Histological Features of Gastritis Based on the Updated Sydney System.

Authors:  Dong-Hoon Kim; Byoung Kwan Son; Kyueng-Whan Min; Sang Kuk Han; Ji Ung Na; Pil Cho Choi; Hack-Lyoung Kim; Mi Jung Kwon; Young Ha Oh; Woon Yong Jung; Ji-Yong Moon; Sangmo Hong; Ki-Wook Oh; Young Seo Kim
Journal:  J Clin Med       Date:  2020-06-14       Impact factor: 4.241
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.